291 related articles for article (PubMed ID: 29843676)
1. Predictors of medication adherence among patients with severe psychiatric disorders: findings from the baseline assessment of a randomized controlled trial (Tecla).
Stentzel U; van den Berg N; Schulze LN; Schwaneberg T; Radicke F; Langosch JM; Freyberger HJ; Hoffmann W; Grabe HJ
BMC Psychiatry; 2018 May; 18(1):155. PubMed ID: 29843676
[TBL] [Abstract][Full Text] [Related]
2. Tecla: a telephone- and text-message based telemedical concept for patients with severe mental health disorders--study protocol for a controlled, randomized, study.
Stentzel U; Grabe HJ; Strobel L; Penndorf P; Langosch J; Freyberger HJ; Hoffmann W; van den Berg N
BMC Psychiatry; 2015 Nov; 15():273. PubMed ID: 26537570
[TBL] [Abstract][Full Text] [Related]
3. Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial.
Stentzel U; van den Berg N; Moon K; Schulze LN; Schulte J; Langosch JM; Hoffmann W; Grabe HJ
BMC Psychiatry; 2021 Jun; 21(1):318. PubMed ID: 34187420
[TBL] [Abstract][Full Text] [Related]
4. Relationship of insight with medication adherence and the impact on outcomes in patients with schizophrenia and bipolar disorder: results from a 1-year European outpatient observational study.
Novick D; Montgomery W; Treuer T; Aguado J; Kraemer S; Haro JM
BMC Psychiatry; 2015 Aug; 15():189. PubMed ID: 26239486
[TBL] [Abstract][Full Text] [Related]
5. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
6. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
7. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study.
Yen CF; Chen CS; Ko CH; Yeh ML; Yang SJ; Yen JY; Huang CF; Wu CC
Psychiatry Clin Neurosci; 2005 Aug; 59(4):403-9. PubMed ID: 16048445
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
9. Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.
Greene M; Yan T; Chang E; Hartry A; Touya M; Broder MS
J Med Econ; 2018 Feb; 21(2):127-134. PubMed ID: 28895758
[TBL] [Abstract][Full Text] [Related]
10. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic benefit of a registered psychoeducation program on treatment adherence, objective and subjective quality of life: French pilot study for schizophrenia].
Sauvanaud F; Kebir O; Vlasie M; Doste V; Amado I; Krebs MO
Encephale; 2017 May; 43(3):235-240. PubMed ID: 27658989
[TBL] [Abstract][Full Text] [Related]
12. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
Jaeger S; Pfiffner C; Weiser P; Kilian R; Becker T; Längle G; Eschweiler GW; Croissant D; Schepp W; Steinert T
Psychiatry Res; 2012 Dec; 200(2-3):83-8. PubMed ID: 22534500
[TBL] [Abstract][Full Text] [Related]
13. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
[TBL] [Abstract][Full Text] [Related]
14. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
15. Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness.
Valenstein M; Kavanagh J; Lee T; Reilly P; Dalack GW; Grabowski J; Smelson D; Ronis DL; Ganoczy D; Woltmann E; Metreger T; Wolschon P; Jensen A; Poddig B; Blow FC
Schizophr Bull; 2011 Jul; 37(4):727-36. PubMed ID: 19933540
[TBL] [Abstract][Full Text] [Related]
16. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
17. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
18. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
[TBL] [Abstract][Full Text] [Related]
19. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
Beebe LH; Smith K; Phillips C
Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
[TBL] [Abstract][Full Text] [Related]
20. Factors Affecting Medication Adherence Among Adults with Schizophrenia: A Literature Review.
Tham XC; Xie H; Chng CM; Seah XY; Lopez V; Klainin-Yobas P
Arch Psychiatr Nurs; 2016 Dec; 30(6):797-809. PubMed ID: 27888977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
